Skip to content

Invest1 publisher3 min readPublished Updated

K-Beauty's Best Trade Is Now the Factory, Not the Brand

Kolmar Korea's operating profit rose 50.2% in the second quarter and all three of Korea's big contract manufacturers set records. The margins say something more complicated.

The Investor · Invest desk

Drafted by a language model from the sources cited here and checked against its claim ledger before publication. How we use AISend a correction

Photograph accompanying K-Beauty's Best Trade Is Now the Factory, Not the Brand
Photo: georgetown.edu

What happened

  • Kolmar Korea's second-quarter revenue rose 17.9% from a year earlier to 861.3 billion won ($628 million), according to preliminary figures.
  • Kolmar Korea's operating profit climbed 50.2% to 110.3 billion won, the highest for any quarter.
  • A Kolmar Korea official said orders increased, centred on skincare and sun-care products, driven by indie brands' overseas expansion and the peak sun-care season, and that new product launches by global clients also continued, giving the company its best quarterly results ever.
  • Cosmax's second-quarter revenue and operating profit were 794.9 billion won and 73.7 billion won, up 27.5% and 21.2% from a year earlier, a record.
  • Revenue at Cosmax's Korean unit rose 23% to 518.4 billion won, topping 500 billion won for the first time in a single quarter.

Compiled by The InvestorSomething wrong?How this is made

Why it matters

Korea's three largest cosmetics ODMs all posted record second-quarter results, led by Kolmar Korea, where operating profit rose 50.2% to 110.3 billion won on revenue of 861.3 billion won, up 17.9% [17][1][2]. That matters because the growth is no longer coming from a handful of large brand owners: it is coming from hundreds of indie labels and global clients placing orders, and the manufacturers collect from all of them regardless of which label wins the shelf [18].

Kolmar attributed the quarter to skincare and sun-care orders driven by indie brands' overseas expansion, peak sun-care season, and continued new product launches by global clients [3]. The operating margin worked out to 12.8%, against roughly 10.1% a year earlier [1][2]. That is the cleanest number in the set, because it shows pricing and mix improving rather than just volume arriving.

Cosmax is the counterexample. Revenue rose 27.5% to 794.9 billion won but operating profit rose only 21.2% to 73.7 billion won, which means the margin slipped to 9.3% from about 9.8% [4][3]. Its Korean unit did 518.4 billion won, up 23% and above 500 billion won in a single quarter for the first time, or about 65% of group revenue [5][6]. The more interesting line is the U.S. unit turning a profit for the first time since it was founded [6]. A long-standing loss centre clearing zero is worth more to the next few years than another point of Korean volume.

Cosmecca Korea ran the best margin of the three at 14.2%, on revenue of 226.1 billion won, up 39.8%, and operating profit of 32.1 billion won, up 39.3% [7][4]. It also beat consensus by roughly 12% on revenue and 16% on operating profit, which the company put down to demand for K-derma skincare lifting export volumes [8][5][9]. Together the three ODMs turned over about 1.88 trillion won in the quarter [13].

Now the part the "shift to manufacturers" story tends to skip. APR posted revenue of 767.5 billion won, up 134.2%, and operating profit of 190.6 billion won, up 134.5%, for a 24.8% operating margin [10][7]. Its North American sales rose 264.6% to 376.3 billion won and European sales rose 380.3% to 145.1 billion won, together about 68% of the quarter [12][9]. First-half revenue of 1.3609 trillion won is already 89% of last year's full-year total [11][8]. Dalba Global ran a 25.3% margin on revenue up 46%, with overseas sales up 74% [13][10]. Brand owners that win keep two to three times the margin of the factories that supply them.

The ODM case is not higher returns, it is lower variance. Brand outcomes are dispersed: Clio grew revenue 6% but lifted operating profit 230% to 11.6 billion won [15]; iFamilySC's Rom&nd grew revenue 2% to a record 58.7 billion won [14]; Aekyung Industrial returned to profit with 4.5 billion won on 194.2 billion won of revenue, a 2.3% margin [16][12]. The manufacturers sit above that spread.

What to watch: whether Cosmax's U.S. profit holds for a second quarter, or was a one-off [6]. Whether Kolmar's margin survives the back half, given that peak sun-care season is seasonal by definition [3][1]. And whether the diversifying export destinations and expanding local distribution the industry is counting on for the second half actually convert into order books, rather than inventory sitting in new retail doors [19].

Loading claim ledger
Loading source directory links
Loading share composer
Loading topic controls
Loading related stories